T2 Biosystems Inc logo

T2 Biosystems Inc

$ 0.10 -0.0081 (-7.64%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 34.51M
Enterprise V:
$ 82.83M
Volume:
14.46M
Avg Vol (2M):
56.41M
Also Trade In:
Volume:
14.46M
Market Cap $:
34.51M
PE Ratio:
At Loss
Avg Vol (2-Month):
56.41M
Enterprise Value $:
82.83M
PB Ratio:
0
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. The company's core technology is T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease.
Name Current Vs Industry Vs History
Cash-To-Debt 0.23
Equity-to-Asset -0.95
Debt-to-Equity -1.56
Debt-to-EBITDA -1.14
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -21.06
Distress
Grey
Safe
Beneish M-Score -4.09
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 40.05
9-Day RSI 38.46
14-Day RSI 39.05
6-1 Month Momentum % -70.13
12-1 Month Momentum % -87.11

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.87
Quick Ratio 1.44
Cash Ratio 1
Days Inventory 83.22
Days Sales Outstanding 54.09
Days Payable 57.92

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -55.6

Financials (Next Earnings Date:2022-11-04 Est.)

TTOO's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:TTOO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 27.553
EPS (TTM) ($) -0.35
Beta 0.35
Volatility % 60.29
14-Day RSI 39.05
14-Day ATR ($) 0.013662
20-Day SMA ($) 0.11113
12-1 Month Momentum % -87.11
52-Week Range ($) 0.089 - 1.08
Shares Outstanding (Mil) 352.54

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

T2 Biosystems Inc Filings

Document Form Filing Date
No Filing Data

T2 Biosystems Inc Analysis

Share your research

Headlines

See More
No news.